Target (CBDY) Total Debt (2015 - 2026)

Target (CBDY) reported Total Debt of $8100.0 for Q1 2026, down 55.9% year-over-year from $18369.0 in Q1 2025, and up 0.53% quarter-over-quarter from $8057.0 in Q4 2025.

Target (CBDY) Total Debt (2015 - 2026) Analysis & Trends

Target (CBDY) has 12 years of Total Debt data on file, last reported at $8100.0 in Q1 2026.

  • Total Debt for Q1 2026 came in at $8100.0, down 55.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $8100.0 (down 55.9% YoY), and the FY2025 annual result was $8057.0, up 1.23% from the prior year.
  • Total Debt climbed to $8100.0 in Q1 2026 per CBDY's latest filing, from $8057.0 in the prior quarter.
  • Over five years, Total Debt peaked at $24159.0 in Q3 2023 and troughed at $7931.0 in Q1 2024.
  • A 5-year average of $11971.5 and a median of $10285.0 in 2025 frame the typical range for Total Debt.
  • The sharpest annual moves came in 2024 and 2025: Total Debt sank 66.99% in 2024, then jumped 131.61% in 2025.
  • A 5-year view of Total Debt shows it stood at $15125.0 in 2022, then tumbled by 46.97% to $8021.0 in 2023, then slipped by 0.77% to $7959.0 in 2024, then increased by 1.23% to $8057.0 in 2025, then rose by 0.53% to $8100.0 in 2026.
  • Business Quant data shows CBDY's Total Debt at $8100.0 in Q1 2026, $8057.0 in Q4 2025, and $7973.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 16.63 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 9.05 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 3.53 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 3.99 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.51 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 570.41 Mn
10 Target - - 191,787.00 8,100.00

Historic Data

Download Data
DateValue
Mar 31, 2026 8,100.00
Dec 31, 2025 8,057.00
Sep 30, 2025 7,973.00
Jun 30, 2025 10,285.00
Mar 31, 2025 18,369.00
Dec 31, 2024 7,959.00
Sep 30, 2024 7,974.00
Jun 30, 2024 16,170.00
Mar 31, 2024 7,931.00
Dec 31, 2023 8,021.00
Sep 30, 2023 24,159.00
Jun 30, 2023 16,318.00
Mar 31, 2023 12,454.00
Dec 31, 2022 15,125.00
Sep 30, 2022 10,678.00
Jun 30, 2021 11,133.00
Mar 31, 2021 27,217.00
Dec 31, 2020 12,068.00
Sep 30, 2020 14,501.00
Jun 30, 2020 14,539.00